- The 5th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 30th to December 2nd, 2017
-
Tominaga E, Kobayashi , Aoki D
- KMID: 2404023
- J Gynecol Oncol.
- 2018 Mar;29(2):e33.
- doi: 10.3802/jgo.2018.29.e33
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
-
Kobayashi , Banno K, Kunitomi H, Tominaga E, Aoki D
- KMID: 2429579
- J Gynecol Oncol.
- 2019 Jan;30(1):e10.
- doi: 10.3802/jgo.2019.30.e10
Ovarian cancer is the seventh most common cancer and the eighth most common cause of cancer mortality in women. Although standard chemotherapy is the established treatment for ovarian cancer, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer
-
Takeda T, Tsuji K, Banno K, Yanokura M, Kobayashi , Tominaga E, Aoki D
- KMID: 2409933
- J Gynecol Oncol.
- 2018 May;29(3):e29.
- doi: 10.3802/jgo.2018.29.e29
OBJECTIVE: Lynch syndrome is a cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes. Lynch syndrome only causes about 0.4% of cases of ovarian cancer, which... -
- CITED
-
- Close
- SHARE
-
- Close
- LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
-
Kunitomi H, Kobayashi , Wu RC, Takeda T, Tominaga E, Banno K, Aoki D
- KMID: 2470864
- J Gynecol Oncol.
- 2020 Mar;31(2):e11.
- doi: 10.3802/jgo.2020.31.e11
OBJECTIVE: With the emerging significance of genetic profiles in the management of endometrial cancer, the identification of tumor-driving genes with prognostic value is a pressing need. The LAMC1 gene, encoding... -
- CITED
-
- Close
- SHARE
-
- Close
